Salesforce looks to strengthen its AI platform, a positive note for J&J

U.S. stocks rose Monday after President Donald Trump announced a deal to end the four-month war between the U.S. and Iran. The S&P 500 climbed 1.85%, the Nasdaq jumped more than 3%, and the Dow reached a new all-time intraday high.

Why did Wall Street markets rally on Monday?

Market gains followed the announcement of a peace agreement between the U.S. and Iran, which is expected to be signed this Friday. According to market data, the S&P 500 is on track for its best day since April 8, while the Nasdaq is headed for its best session since March 31.

Oil prices fell as traders expect the Strait of Hormuz, a primary global shipping channel for oil and gas, to reopen soon. This rally follows a strong previous week, highlighted by the SpaceX IPO, which analysts describe as the biggest IPO of all time.

Did You Know? SpaceX shares rose 19% on Friday following its record-breaking IPO and gained an additional 15% on Monday.

Which sectors lagged during the market surge?

Investors shifted capital away from defensive stocks to purchase companies with higher economic sensitivity. This rotation left four sectors sitting out the rally: health care, energy, real estate, and staples.

Pharmaceutical stocks faced additional pressure after the Centers for Medicare and Medicaid Services announced a new drug-price negotiation proposal. RBC Capital analysts flagged that this proposal could pose headline risks for companies including Merck, Regeneron, Bristol Myers, and Johnson & Johnson.

Expert Insight: Samantha Carter notes that a rotation from defensive sectors into economically sensitive stocks typically indicates that investors are pricing in a lower-risk environment, often triggered by the resolution of geopolitical instability.

What are the latest developments for Johnson & Johnson and Salesforce?

Johnson & Johnson announced an investment of more than $1 billion in Jacksonville, Florida, to expand manufacturing for its Vision business. Separately, Leerink analysts reported a survey of 56 U.S. dermatologists showing that 75% have already prescribed Icotyde, an oral IL-23 inhibitor for plaque psoriasis.

Salesforce announced it will acquire the customer service platform Fin, formerly known as Intercom, for $3.6 billion. The company stated that Fin’s tools will complement its Agentforce platform, which currently generates approximately $1.2 billion in annual recurring revenue.

Despite the acquisition, Salesforce shares extended a losing streak to 10 sessions. Piper Sandler analysts stated the move aims to solidify Salesforce as a dominant AI agent platform in the enterprise market. The deal is expected to close in the fourth quarter of Salesforce’s fiscal year 2027.

What happens next for the markets?

Investors are awaiting the official signing of the U.S.-Iran agreement on Friday. Because the drugmaker group is currently out of favor, analysts suggest pharma stocks may be vulnerable to giving back some of last week’s gains.

IRAN DEAL SHOCKER: Trump announces MAJOR COMPONENTS of historic peace agreement

On Tuesday, the market will monitor the release of May import prices, building permits, and housing starts. No major earnings reports are scheduled before the Tuesday open.

Frequently Asked Questions

Why did oil prices decline on Monday?
Prices fell based on expectations that the Strait of Hormuz, a critical shipping channel for gas and oil, will soon reopen.

How much is Salesforce paying for Fin?
Salesforce is acquiring the platform for $3.6 billion to enhance its AI-powered customer service capabilities via Agentforce.

Which pharmaceutical companies are at risk from new CMS proposals?
According to RBC Capital, the new drug-price negotiation proposal could pose risks for Johnson & Johnson, Merck, Regeneron, and Bristol Myers.

How do you think the shift from defensive stocks to economically sensitive companies will impact your portfolio this quarter?